Our study revealed a higher concentration of anti-inflammatory IL-38 in NAFLD subjects, suggesting IL-38 could be part of a feedback loop to attenuate the observed inflammation. This evidence concerns the gene IL1F10 and metabolic dysfunction-associated steatotic liver disease.